- Home
- DRMA vs ITP Comparison
DRMA vs ITP Comparison
Compare DRMA & ITP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRMA
- ITP
- Stock Information
- Founded
- DRMA 2014
- ITP 1996
- Country
- DRMA United States
- ITP China
- Employees
- DRMA N/A
- ITP N/A
- Industry
- DRMA Biotechnology: Pharmaceutical Preparations
- ITP Paper
- Sector
- DRMA Health Care
- ITP Basic Materials
- Exchange
- DRMA Nasdaq
- ITP Nasdaq
- Market Cap
- DRMA 3.5M
- ITP 3.6M
- IPO Year
- DRMA 2021
- ITP N/A
- Fundamental
- Price
- DRMA $5.48
- ITP $0.20
- Analyst Decision
- DRMA Strong Buy
- ITP
- Analyst Count
- DRMA 1
- ITP 0
- Target Price
- DRMA $10.00
- ITP N/A
- AVG Volume (30 Days)
- DRMA 28.3K
- ITP 397.0K
- Earning Date
- DRMA 08-13-2025
- ITP 08-14-2025
- Dividend Yield
- DRMA N/A
- ITP N/A
- EPS Growth
- DRMA N/A
- ITP N/A
- EPS
- DRMA N/A
- ITP N/A
- Revenue
- DRMA N/A
- ITP $78,416,221.00
- Revenue This Year
- DRMA N/A
- ITP N/A
- Revenue Next Year
- DRMA N/A
- ITP N/A
- P/E Ratio
- DRMA N/A
- ITP N/A
- Revenue Growth
- DRMA N/A
- ITP 12.26
- 52 Week Low
- DRMA $5.09
- ITP $0.15
- 52 Week High
- DRMA $24.90
- ITP $1.07
- Technical
- Relative Strength Index (RSI)
- DRMA 37.22
- ITP 47.04
- Support Level
- DRMA $5.09
- ITP $0.18
- Resistance Level
- DRMA $6.09
- ITP $0.22
- Average True Range (ATR)
- DRMA 0.52
- ITP 0.01
- MACD
- DRMA -0.09
- ITP -0.00
- Stochastic Oscillator
- DRMA 20.22
- ITP 42.25
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical skin diseases and aesthetic applications. Its two product candidates, XYNGARI (formerly known as DMT310) and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases. Dermata announced positive Phase 3 data from its STAR-1 clinical trial in March 2025.
About ITP IT Tech Packaging Inc.
IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.